# VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.

> **NCT03324958** · NA · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 24 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DEVICE:** Virtual reality Helmet
- **OTHER:** No Virtual Reality Helmet

## Key facts

- **NCT ID:** NCT03324958
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-26
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-03-04
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Enrollment difficulties
- **Last updated:** 2022-02-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03324958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03324958, "VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03324958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*